The concept that astrocytes release neuroactive molecules (gliotransmitters) to affect synaptic transmission has been a paradigm shift in neuroscience research over the past decade. This concept suggests that astrocytes, together with pre-and postsynaptic neuronal elements, make up a functional synapse. Astrocyte release of gliotransmitters (for example, glutamate and adenosine triphosphate) is generally accepted to be a Ca 2+ -dependent process. We used two mouse lines to either selectively increase or obliterate astrocytic G q G protein-coupled receptor Ca 2+ signaling to further test the hypothesis that astrocytes release gliotransmitters in a Ca 2+ -dependent manner to affect synaptic transmission. Neither increasing nor obliterating astrocytic Ca 2+ fluxes affects spontaneous and evoked excitatory synaptic transmission or synaptic plasticity. Our findings suggest that, at least in the hippocampus, the mechanisms of gliotransmission need to be reconsidered. C alcium transients in astrocytes are physiologically driven by metabotropic G q G protein-coupled receptors (G q GPCRs), which can be activated after neurotransmitter release from presynaptic terminals (1, 2) . At Schaffer collateral-CA1 (SC-CA1) synapses in acute hippocampal slices, astrocytes can modulate neuronal activity by elevations in Ca 2+ that are evoked by the following: (i) uncaging IP 3 or Ca 2+ in individual astrocytes, (ii) repetitive depolarization of the astrocyte membrane, (iii) mechanical stimulation of an astrocyte, or (iv) bath application of endogenous G q GPCR agonists. With these pharmacological approaches, astrocyte Ca 2+ elevations have been reported to trigger gliotransmitter release from astrocytes, resulting in the modulation of synaptic transmission and plasticity through the activation of presynaptic [for example, group I metabotropic glutamate receptors (mGluRs) or adenosine A(1) receptors (A 1 Rs)] or postsynaptic receptors [N-methyl-D-aspartate receptors (NMDARs)] (3-11). To circumvent a number of caveats associated with the pharmacological approaches described above (12-15), we have recently developed and characterized two genetically modified mice [the MrgA1 + and IP 3 R2 knockout (KO) mice] that enable either selective activation or inactivation of G q GPCR Ca 2+ signaling in astrocytes (13, 16, 17) . Within the hippocampus, the stimulation of transgenic MrgA1 G q GPCRs leads to astrocyte-specific Ca 2+ responses that mimic the "Ca 2+ fingerprint" response that is elicited by endogenous G q GPCRs (13) . In hippocampal slices derived from IP 3 R2 KO mice (17) + passive astrocytes (13) in cell bodies as well as fine processes (Fig. 1, A and B, boxes/ traces 1 to 5, SOM text S2, and movie S1). No significant effect of astrocyte Ca 2+ elevations on sEPSC frequency and amplitude in CA1 neurons from MrgA1 + mice was found ( Fig. 1C and SOM text S3, n = 7, P > 0.05). To test the possibility that this lack of effect might be caused by the stimulation of a transgenic G q GPCR, we also stimulated endogenous astrocytic endothelin G q GPCRs (ETRs), which were selected as optimal candidates because they evoke gliotransmitter release in vitro (18) , they are thought to be very weakly expressed by neurons and heavily expressed by brain astrocytes at postnatal day 1 to 30 (19) , and no direct effects on neuronal activity have been reported when stimulating ETRs (13) . Astrocytic ETR-mediated Ca 2+ increases in~100% of astrocytes from wild-type (WT) hippocampal slices [endothelin 1 (ET1) and ET3, 10 nM each; SOM text S4, and fig. S1) had no effect on the frequency or amplitude of sEPSCs (Fig. 1, D to F, and SOM text S5, n = 5, P > 0.05).
Previous studies using conventional pharmacological approaches have suggested that postsynaptic NMDARs might be preferential targets for glutamate release from astrocytes (3-7, 9, 10), prompting us to examine the possibility that astrocytic G q GPCR Ca 2+ elevations modulate the NMDAR-mediated component of evoked wholecell EPSCs (eEPSCs). FMRF does not produce a nonspecific effect on NMDA eEPSCs (Fig. 2 , A and A1, and SOM text S6). FMRF or ETs were applied to MrgA1 + or WT slices, respectively, and the amplitude of NMDA eEPSCs was unaffected during agonist-mediated Ca 2+ increases in astrocytes (Fig. 2 , B and B1, and SOM text S7, MrgA1 + , n = 11, P > 0.05; Fig. 2 , C and C1, and SOM text S7, WT, n = 7, P > 0.05).
Uncaging IP 3 or Ca 2+ in astrocytes produces a transient enhancement of the probability of neurotransmitter release at a fraction of the SC terminals (10, 20) . We directly tested whether activating or inactivating astrocytic G q GPCR Ca 2+ signaling affects presynaptic release probability and shortterm plasticity by measuring the paired-pulse facilitation (PPF) index of evoked field potentials (fEPSPs). Astrocytic MrgA1R expression by itself did not have a nonspecific effect on PPF (Fig.  2D and SOM text S8). No overall PPF profile changes were observed in association with astrocyte MrgA1R-or ETR-mediated Ca 2+ elevations in MrgA1 + or WT slices, respectively (Fig. 2E , MrgA1 + , n = 7, P > 0.05; Fig. 2F , WT, n = 6, P > 0.05). We reasoned that if astrocytic Ca 2+ elevations regulate gliotransmitter release, then the removal of astrocytic G q GPCR Ca 2+ signaling should affect tonic and activity-induced gliotransmitter release and, consequently, PPF. Therefore, PPF was measured in IP 3 R2 KO mice versus WT littermate controls. Again, no changes in PPF profiles were observed between the two groups (Fig.  2G , IP 3 R2 KO, n = 9; WT, n = 9; P = 0.73).
A recent study has shown that temporal coincidence of astrocyte Ca 2+ elevations (evoked by Ca 2+ uncaging) and transient depolarization of CA1 neurons can induce a presynaptic form of long-term potentiation (LTP) in SC-CA1 synapses (10) . Therefore, stimulating astrocytic G q GPCR Ca 2+ signaling simultaneously with depolarization of large ensembles of CA1 neurons should either directly induce LTP or at least modulate the baseline slope of fEPSPs through gliotransmitter activation of presynaptic group I mGluRs, or, alternatively, A 1 Rs (10, 21). Our data do not support these predictions ( fig. S2, B, B1, C, C1 , and SOM text S9).
We also directly tested whether astrocytic G q GPCRs regulate LTP magnitude as well as posttetanic potentiation (PTP). Similar to PPF, PTP is a form of short-term plasticity (22) . First, a battery of control experiments clearly demonstrated that neither the selective astrocytic expression of MrgA1Rs nor the application of FMRF to WT slices affected input-output (I/O) curves, PTP, or LTP (Fig. 3, A and D, and SOM text S10) . A prerequisite for the involvement of astrocytes in LTP is that their activation precedes the induction of LTP. After establishing a 15-min baseline recording of fEPSPs, Ca 2+ elevations in astrocytes were induced by bath application of either FMRF to MrgA1 + slices or ETs to WT slices. LTP was induced~2.5 min after agonist application, when the peaks of Ca 2+ responses in astrocytes reached their maximum (Fig. 3, B stimulated with FMRF (137.97 T 5.58%, n = 14 slices) or WT slices stimulated with ETs (133.13 T 7.62%, n = 9), respectively, were no different from LTP magnitudes obtained in matching controls (Fig. 3, E and F, and SOM text S11, P > 0.05). Furthermore, PTP was also not affected (Fig. 3 , E and F, and SOM text S11, P > 0.05).
Next, we examined whether the obliteration of astrocytic G q GPCR Ca 2+ signaling would affect basal synaptic transmission as well as PTP and LTP. No significant difference was found in I/O curves performed in IP 3 R2 KO versus WT littermate control mice (Fig. 3G, IP 3 R2 KO, n = 21; WT, n = 18; P = 0.94). These results indicate that both the pre-and postsynaptic responses, and thus the basal SC-evoked synaptic transmission, are intact in IP 3 R2 KO mice, even though astrocytes are completely incapable of producing G q GPCR Ca 2+ elevations. No significant alteration in PTP and LTP was detected between IP 3 R2 KO and control mice, demonstrating that astrocytic G q GPCR-mediated Ca 2+ signaling does not account for a tonic form nor an activity-induced form of short-and long-term synaptic plasticity (Fig. 3H and SOM text S12, IP 3 R2 KO, n = 10; WT, n = 8, P > 0.05). To validate these IP 3 R2 KO data, we showed that the LTP stimulation protocol used is sufficient to induce Ca 2+ increases in astrocytes from WT slices ( fig. S3) . Finally, we also found that stimulating or removing astrocytic G q GPCR Ca 2+ signaling in MrgA1 + or IP 3 R2 KO mice, respectively, does not significantly alter LTP and PTP induced by theta-burst stimulation (SOM text S13).
Previous studies have demonstrated that activation of synaptic group I mGluRs, A 1 Rs, or NMDARs depotentiates LTP at SC-CA1 synapses (23) (24) (25) (26) (27) . These three receptors have all been reported to be the targets of astrocytic Ca 2+ -dependent sources of glutamate or adenosine triphosphate (ATP)/adenosine under certain conditions (12) . To further test whether astrocytic G q GPCR Ca 2+ signaling is sufficient to induce gliotransmitter release to affect synaptic transmission through the activation of synaptic mGluRs, A 1 Rs, or NMDARs, we investigated the role of astrocyte Ca 2+ signaling in the maintenance of LTP. Fifty minutes after LTP induction, astrocyte Ca 2+ increases were elicited by applications of FMRF to MrgA1 + slices or of ETs to WT slices. This did not lead to a significant change in the slope of fEPSPs (Fig. 4, A, B, and D, and SOM text S14, n = 9 MrgA1 + slices, n = 16 WT slices, P > 0.05). As a positive control for agonist-induced depotentiation, we applied (RS)-3,5-dihydroxyphenylglycine (DHPG, 50 mM), which exerted a significant depotentiation of the slope in all slices tested (Fig.  4, A and D Fig. 4, B and D; WT, 79.54 T 2.03%, n = 11, P < 0.0001). To address the possibility that the DHPG-mediated depotentiation could be due in part to astrocyte Ca 2+ , we performed the same experiments using IP 3 R2 KO mice. The magnitude of DHPG-induced depotentiation in IP 3 R2 KO slices was not only significant (P < 0.0001), it was also similar to the magnitude of depotentiation that was recorded in WT littermate slices (P = 0.43), indicating that depotentiation does not rely, even in part, on Ca 2+ -dependent gliotransmitter release from astrocytes (Fig. 4, C and D ; IP 3 R2 KO, 66.95 T 2.79%, n = 6; WT, 72.70 T 5.72%, n = 8). These results demonstrate and confirm previous data that DHPG-induced modulation of neuronal activity (28, 29) , such as depotentiation (26) , is due to the direct action of DHPG on neuronal group I mGluRs (26) , and not to astrocytic group I mGluR-mediated Ca 2+ elevations and putative gliotransmitter release.
We provide here strong evidence that G q GPCR Ca 2+ signaling in astrocytes does not affect spontaneous and evoked excitatory action potential (AP)-mediated synaptic transmission or short-and long-term plasticity at the SC-CA1 synapse. We used two molecular tools (the MrgA1 + and IP 3 R2 KO mouse models), as well as the activation of endogenous astrocytic G q GPCRs, to manipulate Ca 2+ in astrocytes. A battery of eight electrophysiological protocols (sEPSCs, NMDA eEPSCs, evoked AMPA fEPSPs, I/O curves, PPF, PTP, and two forms of LTP) were studied, all of which point to a lack of modulation of excitatory AP-mediated synaptic transmission by astrocytic G q GPCR Ca 2+ signaling. The most logical conclusion from the present analysis is that astrocytic G q GPCRs and Ca 2+ signaling activity are not tied to the release of gliotransmitters affecting synaptic transmission or short and long-term plasticity. Therefore, our results suggest that gliotransmission reflects the pharmacological approaches that were used in previous studies (3) (4) (5) (6) (7) (8) (9) (10) 12 ) and, at least within the hippocampus, does not occur when the endogenous regulators of astrocyte Ca 2+ , the G q GPCRs, or the IP 3 R2 themselves are stimulated or inactivated in a cellular-selective manner. These findings suggest that the mechanisms of gliotransmitter release should be reconsidered. These results have profound implications for our understanding of synaptic transmission and should affect the interpretation of a broad range of findings. Thus, the purpose of neuron-to-astrocyte G q GPCR Ca 2+ signaling in neurophysiology remains an open question.
